Scintigraphic Improvement of Primary Intestinal Lymphangiectasia in a Patient Treated With Alpelisib for a PIK3CA-Related Overgrowth Spectrum. Dubois J, Vauchot F. Clin Nucl Med 2025;50:527-530.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Dubois J, Vauchot F. Scintigraphic Improvement of Primary Intestinal Lymphangiectasia in a Patient Treated With Alpelisib for a PIK3CA-Related Overgrowth Spectrum. Clin Nucl Med 2025;50:527-530.
PMID: 39957058